12 West Capital Management LP Repligen Corp Transaction History

12 West Capital Management LP

$610 Million
Q1 2025

A detailed history of 12 West Capital Management LP transactions in Repligen Corp stock. As of the latest transaction made, 12 West Capital Management LP holds 241,233 shares of RGEN stock, worth $26.9 Million. This represents 5.03% of its overall portfolio holdings.

Number of Shares

241,233

Previous 246,875 2.29%

Holding current value

$26.9 Million

Previous $35.5 Million 13.62%

% of portfolio

5.03%

Previous 3.93%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$127.24 - $174.24 $717,888 - $983,062	-5,642 Reduced 2.29%	241,233 $30.7 Million
Q4 2024 Feb 13, 2025	SELL	$123.41 - $160.92 $737,251 - $961,336	-5,974 Reduced 2.36%	246,875 $35.5 Million
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $19.7 Million - $24.1 Million	-115,396 Reduced 31.34%	252,849 $46.5 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $5.25 Million - $8.52 Million	-45,972 Reduced 11.1%	368,245 $66.2 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $9.2 Million - $11.7 Million	-66,281 Reduced 13.79%	414,217 $65.9 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $12.5 Million - $16.3 Million	-90,647 Reduced 15.87%	480,498 $68 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $14.9 Million - $19.1 Million	-96,476 Reduced 14.45%	571,145 $96.2 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $20.8 Million - $28.2 Million	-127,812 Reduced 16.07%	667,621 $113 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.8 Million - $4.47 Million	-17,430 Reduced 2.14%	795,433 $149 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $41,359 - $55,277	-294 Reduced 0.04%	812,863 $132 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $150,229 - $240,418	932 Added 0.11%	813,157 $153 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $51.8 Million - $63.8 Million	-209,416 Reduced 20.5%	812,225 $215 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $10.4 Million - $17.3 Million	-53,412 Reduced 4.97%	1,021,641 $295 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $2.78 Million - $3.7 Million	-16,754 Reduced 1.53%	1,075,053 $215 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $1.91 Million - $2.39 Million	-10,576 Reduced 0.96%	1,091,807 $212 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $7.18 Million - $10.7 Million	-76,141 Reduced 6.46%	1,102,383 $136 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $13.7 Million - $17.2 Million	185,000 Added 18.62%	1,178,524 $109 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $36.6 Million - $45.7 Million	478,000 Added 92.72%	993,524 $76.2 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $27.9 Million - $44.3 Million	515,524 New	515,524 $44.3 Million

Others Institutions Holding RGEN

# of Institutions

492

Shares Held

57.7M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.18B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on 12 West Capital Management LP with notifications on news.

Account

12 West Capital Management LP Repligen Corp Transaction History